Literature DB >> 22547756

Food and Drug Administration's Obesity Drug Guidance Document: a short history.

Eric Colman1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22547756     DOI: 10.1161/CIRCULATIONAHA.111.028381

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  21 in total

1.  Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide.

Authors:  Andrew J Krentz; Ken Fujioka; Marcus Hompesch
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

2.  The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.

Authors:  Anita Chawla; Ginger Carls; Edmund Deng; Edward Tuttle
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

3.  Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors.

Authors:  Ankur Jindal; Stephen Brietzke; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-24       Impact factor: 2.041

4.  One-year effects of a group-based lifestyle intervention in adults with type 2 diabetes: A randomized encouragement trial.

Authors:  David T Liss; Emily A Finch; Andrew Cooper; Avani Sheth; Ashantí D Tejuosho; Nicola Lancki; Ronald T Ackermann
Journal:  Diabetes Res Clin Pract       Date:  2018-03-27       Impact factor: 5.602

Review 5.  Legend of Weight Loss: a Crosstalk Between the Bariatric Surgery and the Brain.

Authors:  Ziwei Lin; Shen Qu
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

6.  Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.

Authors:  David T Liss; Emily A Finch; Dyanna L Gregory; Andrew Cooper; Ronald T Ackermann
Journal:  Contemp Clin Trials       Date:  2015-12-02       Impact factor: 2.226

Review 7.  Long-term drug treatment for obesity: a systematic and clinical review.

Authors:  Susan Z Yanovski; Jack A Yanovski
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

8.  US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity.

Authors:  G Gomez; F C Stanford
Journal:  Int J Obes (Lond)       Date:  2017-11-20       Impact factor: 5.095

Review 9.  Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.

Authors:  A S Kelly; C K Fox; K D Rudser; A C Gross; J R Ryder
Journal:  Int J Obes (Lond)       Date:  2016-04-26       Impact factor: 5.095

10.  A randomized feasibility pilot trial of a financial incentives intervention for dietary self-monitoring and weight loss in adults with obesity.

Authors:  Corrine I Voils; Jane Pendergast; Sarah L Hale; Jennifer M Gierisch; Elizabeth M Strawbridge; Erica Levine; Megan A McVay; Shelby D Reed; William S Yancy; Ryan J Shaw
Journal:  Transl Behav Med       Date:  2021-04-26       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.